Stockreport

Aimmune Therapeutics reports Q4 results [Seeking Alpha]

AIMMUNE THERAPEUTICS  (AIMT) 
Last aimmune therapeutics earnings: 2/27 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.aimmune.com/corporate-profile
PDF Aimmune Therapeutics reports Q4 resultsAimmune Therapeutics (NASDAQ:AIMT): Q4 EPS of -$0.81Press ReleaseClick to subscribe to real-time analytics on AIMTNow read:How Doe [Read more]